Pertussis immunisation in pregnancy: a summary of funded Australian state and territory programs

Frank H Beard1

  • 1Staff Specialist - Public Health Physician, National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Westmead, New South Wales.

Insights

Pertussis vaccination during pregnancy is now recommended in Australia to protect infants. This report compares state and territory programs, highlighting similarities and differences in implementation.

Area of Science:

  • Public Health
  • Immunisation
  • Vaccinology

Background:

  • The Australian Immunisation Handbook (10th ed.) recommends pertussis vaccination during pregnancy.
  • This strategy aims to protect vulnerable newborns from pertussis (whooping cough).
  • Pertussis immunisation programs for pregnant women were implemented across Australian states and territories between August 2014 and June 2015.

Purpose of the Study:

  • To compare jurisdictional pertussis immunisation programs for pregnant women in Australia.
  • To share information on policies and program implementation.
  • To provide the first published comparison of these state-level programs.

Main Methods:

  • A meeting was convened by the National Centre for Immunisation Research and Surveillance (NCIRS) on May 31, 2015.
  • Participants shared information regarding jurisdictional policies and program implementation.
  • The meeting report provides a comparison of the implemented programs.

Main Results:

  • Jurisdictional pertussis immunisation programs for pregnant women are broadly similar.
  • Important differences exist between the state and territory programs.
  • This represents the first published comparison of these programs.

Conclusions:

  • Monitoring and evaluation of pertussis vaccination programs during pregnancy are crucial.
  • Data on uptake, safety, and impact will inform future policy decisions.
  • Continued surveillance is essential for optimising infant protection against pertussis.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
53.7K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.1K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.5K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.0K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.2K
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
55